Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Cardiovascular disease in pediatric chronic dialysis patients
Blanche M. Chavers
, Shuling Li
, Allan J. Collins
, Charles A. Herzog
Pediatric Nephrology
Medicine - Renal and Hypertension Division
Medicine - Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
191
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cardiovascular disease in pediatric chronic dialysis patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pediatric
100%
Cardiomyopathy
100%
Cardiovascular Disease
100%
Chronic Dialysis Patients
100%
Arrhythmia
60%
Cardiac Arrest
40%
People of Color
40%
Cardiac Mortality
40%
Valvular Heart Disease
40%
Cardiac Morbidity
40%
Medicare
20%
Statistical Analysis
20%
Cause of Death
20%
End-stage Renal Disease
20%
United States Renal Data System (USRDS)
20%
Risk for Cardiovascular Diseases
20%
Dialysis Patients
20%
Disease Incidence
20%
Chi-square Test
20%
Black Adolescents
20%
Valvular Disease
20%
Black children
20%
Cardiac Death
20%
Black Females
20%
Preadolescent children
20%
Poisson Regression Model
20%
Female children
20%
Nursing and Health Professions
Pediatrics
100%
Myocardial Disease
100%
Cardiovascular Disease
100%
Heart Arrhythmia
60%
Morbidity
60%
Heart Arrest
40%
Valvular Heart Disease
40%
Medicare
20%
End Stage Renal Disease
20%
Chi Square Test
20%
Heart Death
20%
Diseases
20%
Economic and Social Development
20%
Youth
20%
Medicine and Dentistry
Pediatrics
100%
Myocardial Disease
100%
Cardiovascular Disease
100%
Cardiac Dysrhythmia
60%
Morbidity
60%
Valvular Heart Disease
40%
Heart Arrest
40%
Medicare
20%
Adolescence
20%
End Stage Renal Disease
20%
Heart Death
20%
Chi Square Test
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Myocardial Disease
100%
Cardiovascular Disease
100%
Morbidity
60%
Heart Arrhythmia
60%
Heart Arrest
40%
Valvular Heart Disease
40%
End Stage Renal Disease
20%
Heart Death
20%
Diseases
20%